323 related articles for article (PubMed ID: 24882784)
21. Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors.
Sevcenco S; Heinz-Peer G; Ponhold L; Javor D; Kuehhas FE; Klingler HC; Remzi M; Weibl P; Shariat SF; Baltzer PA
Eur J Radiol; 2014 Jun; 83(6):909-913. PubMed ID: 24709332
[TBL] [Abstract][Full Text] [Related]
22. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
[TBL] [Abstract][Full Text] [Related]
23. Clear Cell Papillary Renal Cell Carcinoma: A Recent Entity With Distinct Imaging Patterns.
Tordjman M; Dbjay J; Chamouni A; Morini A; Timsit MO; Mejean A; Vasiliu V; Eiss D; Correas JM; Verkarre V; Helenon O
AJR Am J Roentgenol; 2020 Mar; 214(3):579-587. PubMed ID: 31770020
[No Abstract] [Full Text] [Related]
24. Are growth patterns on MRI in small (< 4 cm) solid renal masses useful for predicting benign histology?
Lim RS; McInnes MDF; Siddaiah M; Flood TA; Lavallee LT; Schieda N
Eur Radiol; 2018 Aug; 28(8):3115-3124. PubMed ID: 29492598
[TBL] [Abstract][Full Text] [Related]
25. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
26. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
27. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer.
Chandarana H; Rosenkrantz AB; Mussi TC; Kim S; Ahmad AA; Raj SD; McMenamy J; Melamed J; Babb JS; Kiefer B; Kiraly AP
Radiology; 2012 Dec; 265(3):790-8. PubMed ID: 23175544
[TBL] [Abstract][Full Text] [Related]
28. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
29. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
30. Complex renal cysts: findings on MR imaging.
Balci NC; Semelka RC; Patt RH; Dubois D; Freeman JA; Gomez-Caminero A; Woosley JT
AJR Am J Roentgenol; 1999 Jun; 172(6):1495-500. PubMed ID: 10350279
[TBL] [Abstract][Full Text] [Related]
31. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
32. [Characterization and staging of renal tumors: significance of MRI diagnostics].
Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A
Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
[TBL] [Abstract][Full Text] [Related]
33. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis.
Pedrosa I; Sun MR; Spencer M; Genega EM; Olumi AF; Dewolf WC; Rofsky NM
Radiographics; 2008; 28(4):985-1003. PubMed ID: 18635625
[TBL] [Abstract][Full Text] [Related]
34. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
35. An imaging protocol for dynamic contrast-enhanced breast MRI with 3.0T: using sagittal sequence interleaved between axial sequences.
Park JE; Lee JE; Hwang JY; Cha ES
Acta Radiol; 2013 Jul; 54(6):608-13. PubMed ID: 23486561
[TBL] [Abstract][Full Text] [Related]
36. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases?
Schmid-Tannwald C; Thomas S; Ivancevic MK; Dahi F; Rist C; Sethi I; Oto A
Acta Radiol; 2014 Jun; 55(5):515-23. PubMed ID: 23986455
[TBL] [Abstract][Full Text] [Related]
38. Early-stage clear cell tubulopapillary renal cell carcinoma: imaging features and distinction from clear cell and papillary subtypes.
Mnatzakanian GN; Shinagare AB; Sahni VA; Hirsch MS; Silverman SG
Abdom Radiol (NY); 2016 Nov; 41(11):2187-2195. PubMed ID: 27383741
[TBL] [Abstract][Full Text] [Related]
39. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.
Jeon HG; Lee SR; Kim KH; Oh YT; Cho NH; Rha KH; Yang SC; Han WK
Urology; 2010 Sep; 76(3):574-9. PubMed ID: 20303148
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach.
Hötker AM; Mazaheri Y; Wibmer A; Karlo CA; Zheng J; Moskowitz CS; Tickoo SK; Russo P; Hricak H; Akin O
AJR Am J Roentgenol; 2017 Mar; 208(3):W85-W91. PubMed ID: 28095036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
